26 Jun 2019

CHARING CROSS 2019: MEDTRONIC EXPANDS ON KEY AORTIC SOLUTIONS FOR CHALLENGING ANATOMIES

  Medtronic plc released new data on endovascular repair of abdominal aortic aneurysm (AAA) patients with the Endurant II/IIs stent graft system in combination with Heli-FX EndoAnchor implants and for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR). The data, which was presented at the Charing Cross

0
26 Jun 2019

ABBVIE ACQUIRING ALLERGAN AS HEDGE AGAINST EXPIRATION OF HUMIRA PATENT

As a hedge against the 2023 expiration of its U.S. patents that protect its blockbuster drug, Humira, AbbVie Inc. will acquire Dublin, Ireland-based Allergan for $63 billion in cash and stock.     Humira sales account for more than 60 percent of AbbVie’s revenue, but biosimilar drugs approved in Europe

0
21 Jun 2019

CMS ISSUES RENEWED GUIDANCE IN EFFORT TO ENSURE MEDICAID PROGRAM INTEGRITY

The Centers for Medicare & Medicaid Services (CMS) issued guidance to state Medicaid agencies June 21 that outlines the necessary assurances that states should make to ensure that program resources are reserved for those who meet eligibility requirements. This guidance follows a series of steps that CMS has taken since

0
19 Jun 2019

VSA, PRACTICE MANAGEMENT FIRM, OBSERVES 17TH YEAR

  Vein Centers of America (VSA) is celebrating its 17th anniversary by offering a complimentary phone consultation with President and CEO David Schmiege.              in vein-specific practice management, marketing and revenue cycle management initiatives nationwide. “We have the experience, flexibility, structure and size to implement results quickly and to create the culture

0
12 Jun 2019

BUTTERFLY IQ WINS CE MARK FOR IPHONE-BASED PORTABLE ULTRASOUND SYSTEM  

            Connecticut-based Butterfly Network, already selling in the United States, has won the CE Mark and is releasing its single-probe, hand-held, full-body Butterfly iQ portable ultrasound system in Europe. The product consists of a transducer that plugs right into an iPhone or iPad via the Lightning port, and uses a

0
12 Jun 2019

PK PAPYRUS NOW AVAILABLE IN U.S. FOR CRISIS CORONARY PERFORATIONS

              BIOTRONIK is releasing in the United States its PK Papyrus-covered coronary stent, the first new device in many years to be used as an emergency therapy for acute coronary perforations. Because so few of these are expected to be used, but are expected to save many lives, the FDA

0
12 Jun 2019

VEINPIX ALLOWS PATIENTS TO SEND LEG PIXS  QUESTIONS FROM HOME

Realizing the benefits of telemedicine for both medical practices and their patients, Vein Specialists of America (VSA) has created a virtual vein screening platform to give vein practices nationwide the ability to offer virtual screenings to their patients. VeinPIX is a professional way for vein practices to encourage patients to

0
12 Jun 2019

LEGSTHERAPYAPY.COM OFFERS VENACTIVE COMPRESSION SOCKS

LegsTherapyapy.com is offering VenActive Active Comfort Unisex 15-20 mmHg moderate compression socks designed for work or everyday wear. Moderate compression is encouraged for tired, .achy legs, occupational swelling or evening edema, and leg discomfort from long hours of standing or sitting The Venactive Active Comfort Unisex 15-20 mmHg cushioned compression

0
12 Jun 2019

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

    The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

0
12 Jun 2019

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

    By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”

0